Xtx Topco LTD Axsome Therapeutics, Inc. Transaction History

Xtx Topco LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$65.72 - $80.5 $471,409 - $577,426	7,173 Added 177.9%	11,205 $902,000
Q1 2024 May 13, 2024	BUY	$69.39 - $97.64 $279,780 - $393,684	4,032 New	4,032 $321,000
Q3 2023 Nov 13, 2023	BUY	$69.25 - $82.21 $105,260 - $124,959	1,520 Added 53.0%	4,388 $306,000
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $167,519 - $259,123	2,868 New	2,868 $206,000
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $245,640 - $475,818	6,812 New	6,812 $304,000
Q2 2021 Aug 12, 2021	SELL	$50.63 - $73.5 $236,948 - $343,980	-4,680 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$55.91 - $81.44 $261,658 - $381,139	4,680 New	4,680 $265,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.